Press release
Impact Of Rising TB-HIV Co-Infection Rates On The Growth Of The Market: A Key Factor Shaping the Future of the Tuberculosis Therapeutics Market in 2025
Tuberculosis Therapeutics Market Size
There has been a substantial expansion in the tuberculosis therapeutics market over the past few years. Anticipated to escalate from $1.88 billion in 2024 to $2.01 billion in 2025, the compound annual growth rate (CAGR) would be 6.58%. The remarkable uptick during the historic era is owing to the surge in tuberculosis cases, heightened use of tuberculosis therapeutics, improved understanding of tuberculosis (TB), growing instances of XDR-TB, and the rising prevalence of drug-resistant tuberculosis.
In the coming years, the market size for tuberculosis therapeutics is projected to undergo significant growth. The market is forecasted to increase to $2.57 billion in 2029, with a compound annual growth rate (CAGR) of 6.32%. Several factors contribute to growth during the forecast period, such as enhanced investment in healthcare infrastructure, improved awareness and education, increased research and development funding, higher product approvals for various anti-TB agents, augmented research financing, and a rise in the population of elderly individuals. Key trends during the forecast period encompass advancements in pharmaceutical development, customized medicines, combination treatments, digital health solutions, AI, and machine learning for drug discovery.
What Are the Main Catalysts for Growth in the Tuberculosis Therapeutics Market?
Anticipations for the growth of the tuberculosis therapeutics market rest on the increasing prevalence of co-infections (TB-HIV). This term signifies the concurrent infection of individuals with tuberculosis (TB) and the human immunodeficiency virus (HIV). The escalations in co-infection rates (TB-HIV) can be attributed to a weaker immune system inflicted by HIV, making the person more susceptible to tuberculosis. This vulnerability, coupled with the global convergence of both pandemics in high-risk clusters, causes the surge. Tuberculosis therapeutics come to the rescue by delivering bespoke treatments addressing both TB infection and HIV-related immune depression. This approach enhances overall patient prognosis while mitigating the severity of both diseases. Quoting an example from gov.uk, a public sector in the UK, reported 3,805 fresh HIV diagnoses in England in October 2023. This statistic was a substantial 22% leap from the 3,118 cases registered in 2021. Ergo, the soaring co-infection rates (TB-HIV) are boosting the tuberculosis therapeutics market's expansion.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20983&type=smp
Which Businesses Are at the Forefront of Tuberculosis Therapeutics Market Development?
Major companies operating in the tuberculosis therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Macleods Pharmaceuticals Ltd., Cipla Limited, Hikma Pharmaceuticals plc, Lupin Limited, Alkem Laboratories Limited, Emcure Pharmaceuticals Limited, Otsuka Pharmaceutical Co. Ltd., Sequella Inc.
What Are the Emerging Trends in the Tuberculosis Therapeutics Industry?
Trend 1.
Text: Leading corporations in the tuberculosis therapeutics market are concentrating their efforts on the creation of innovative solutions, such as combination therapy. This is intended to augment treatment effectiveness, shorten therapy duration, and fight drug-resistant strains of tuberculosis. Combination therapy is the use of two or more medicines from diverse classes to combat a disease, seeking to escalate treatment effectiveness, minimize resistance, and better patient consequences. For example, in July 2024, Johnson & Johnson, a pharmaceutical company from the US, reached a significant milestone in tuberculosis treatment with the joint approval of SIRTURO (bedaquiline) by the U.S. FDA and the European Commission. This groundbreaking drug is the first in over 40 years specifically engineered to target multidrug-resistant tuberculosis (MDR-TB). It prevents the ATP synthase enzyme, vital to TB bacteria's energy generation, resulting in a focused and effective treatment method. Its usage in combination therapies elevates the overall effectiveness of MDR-TB regimens, shortens therapy length, and boosts patient adherence.
How Is the Tuberculosis Therapeutics Market Segmented?
The tuberculosis therapeutics market covered in this report is segmented -
1) By Type: Active Tuberculosis (TB), Latent Tuberculosis (TB)
2) By Product Type: Isoniazid, Rifampin, Pyrazinamide, Hydrazine derivatives, Miscellaneous anti-tubercular drugs, Ethambutol
3) By Route of Administration: Oral, Parenteral, Other route of administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Active Tuberculosis (TB): First-Line Drugs (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol), Second-Line Drugs (Fluoroquinolones, Aminoglycosides), Combination Therapies, Drug-Resistant TB Treatments (MDR-TB, XDR-TB)
2) By Latent Tuberculosis (TB): Isoniazid Prophylaxis, Rifampicin-Based Regimens, Rifapentine-Based Regimens, Combination Prophylactic Therapies
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/tuberculosis-therapeutics-global-market-report
Where Is the Tuberculosis Therapeutics Market Growth Most Prominent?
North America was the largest region in the tuberculosis therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tuberculosis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Tuberculosis Therapeutics Global Market Report?
- Market Size Analysis: Analyze the tuberculosis therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the tuberculosis therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall tuberculosis therapeutics market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the tuberculosis therapeutics market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20983
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Rising TB-HIV Co-Infection Rates On The Growth Of The Market: A Key Factor Shaping the Future of the Tuberculosis Therapeutics Market in 2025 here
News-ID: 3877506 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does.
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…
